ASND – Ascendis Pharma A/S
Ascendis Pharma A/SASND
$256.59Name : Ascendis Pharma A/S
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $16,884,555,776.00
EPSttm : 13.05
Ascendis Pharma A/S
$256.59
1.25%$3.26
ASND — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
4.83
Margin Of Safety %
-23
Put/Call OI Ratio
0.58
EPS Next Q Diff
EPS Last/This Y
14.3
EPS This/Next Y
-1.18
Price
256.56
Target Price
305.21
Analyst Recom
1.18
Performance Q
0.44
Upside
-33.5%
Beta
0.38
Ticker: ASND
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | ASND | 226.96 | 0.47 | 0.04 | 12476 |
| 2026-10-13 | ASND | 223.21 | 0.47 | 0.60 | 12487 |
| 2026-10-14 | ASND | 227.18 | 0.47 | 1.07 | 12473 |
| 2026-10-15 | ASND | 226.49 | 0.46 | 11.37 | 12427 |
| 2026-10-16 | ASND | 225.05 | 0.47 | 1.93 | 12546 |
| 2026-10-19 | ASND | 228.59 | 0.54 | 0.18 | 9253 |
| 2026-10-20 | ASND | 234.28 | 0.52 | 1.60 | 9591 |
| 2026-10-21 | ASND | 238.84 | 0.52 | 1.39 | 9600 |
| 2026-10-22 | ASND | 242.79 | 0.52 | 0.90 | 9629 |
| 2026-10-23 | ASND | 243.27 | 0.52 | 1.33 | 9674 |
| 2026-10-26 | ASND | 244.15 | 0.52 | 0.08 | 9690 |
| 2026-10-27 | ASND | 245.94 | 0.52 | 1.05 | 9795 |
| 2026-10-28 | ASND | 249.86 | 0.54 | 0.52 | 9856 |
| 2026-10-29 | ASND | 252.95 | 0.57 | 1.04 | 10094 |
| 2026-10-30 | ASND | 251.04 | 0.59 | 0.18 | 10131 |
| 2026-11-02 | ASND | 248.87 | 0.59 | 0.14 | 10135 |
| 2026-11-03 | ASND | 250.28 | 0.59 | 1.67 | 10141 |
| 2026-11-04 | ASND | 258.06 | 0.59 | 0.40 | 10142 |
| 2026-11-05 | ASND | 253.27 | 0.59 | 0.21 | 10145 |
| 2026-11-06 | ASND | 256.77 | 0.58 | 0.44 | 10253 |
| 2026-11-09 | ASND | 259.68 | 0.58 | 0.08 | 10275 |
| 2026-11-10 | ASND | 255.59 | 0.58 | 0.59 | 10311 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | ASND | 226.89 | - | 596.4 | 12.79 |
| 2026-10-13 | ASND | 223.30 | - | 590.2 | 12.79 |
| 2026-10-14 | ASND | 227.07 | - | 615.2 | 12.79 |
| 2026-10-15 | ASND | 226.54 | - | 613.1 | 12.79 |
| 2026-10-16 | ASND | 225.24 | - | 594.2 | 12.79 |
| 2026-10-19 | ASND | 229.76 | - | 614.6 | 12.79 |
| 2026-10-20 | ASND | 229.76 | - | 614.6 | 12.79 |
| 2026-10-21 | ASND | 234.16 | - | 630.7 | 12.79 |
| 2026-10-22 | ASND | 243.05 | - | 609.8 | 12.79 |
| 2026-10-23 | ASND | 243.19 | - | 595.4 | 12.79 |
| 2026-10-26 | ASND | 245.26 | - | 600.4 | 12.79 |
| 2026-10-27 | ASND | 245.99 | - | 596.8 | 11.32 |
| 2026-10-28 | ASND | 249.76 | - | 610.2 | 11.32 |
| 2026-10-29 | ASND | 253.04 | - | 603.5 | 10.08 |
| 2026-10-30 | ASND | 251.12 | - | 585.8 | 10.08 |
| 2026-11-02 | ASND | 248.95 | - | 584.0 | 10.08 |
| 2026-11-03 | ASND | 249.91 | - | 586.6 | 10.08 |
| 2026-11-04 | ASND | 257.95 | - | 614.3 | 10.08 |
| 2026-11-05 | ASND | 253.31 | - | 574.6 | 10.08 |
| 2026-11-06 | ASND | 256.77 | - | 601.1 | 10.08 |
| 2026-11-09 | ASND | 259.77 | - | 601.1 | 10.08 |
| 2026-11-10 | ASND | 256.56 | - | 579.2 | 10.08 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | ASND | -2.49 | 0.94 | 5.37 |
| 2026-10-13 | ASND | -2.49 | 0.94 | 5.37 |
| 2026-10-14 | ASND | -2.49 | 0.94 | 5.37 |
| 2026-10-15 | ASND | -2.49 | 0.94 | 5.37 |
| 2026-10-16 | ASND | -2.49 | 0.94 | 5.37 |
| 2026-10-19 | ASND | -2.49 | 0.99 | 5.37 |
| 2026-10-20 | ASND | -2.49 | 0.99 | 5.37 |
| 2026-10-21 | ASND | -2.49 | 0.99 | 5.37 |
| 2026-10-22 | ASND | -2.49 | 0.99 | 5.37 |
| 2026-10-23 | ASND | -2.49 | 0.99 | 5.37 |
| 2026-10-26 | ASND | -2.49 | 1.06 | 5.37 |
| 2026-10-27 | ASND | -2.49 | 1.06 | 4.83 |
| 2026-10-28 | ASND | -2.49 | 1.06 | 4.83 |
| 2026-10-29 | ASND | -2.49 | 1.06 | 4.83 |
| 2026-10-30 | ASND | -2.49 | 1.06 | 4.83 |
| 2026-11-02 | ASND | -2.49 | 1.09 | 4.83 |
| 2026-11-03 | ASND | -2.49 | 1.09 | 4.83 |
| 2026-11-05 | ASND | -2.49 | 1.09 | 4.83 |
| 2026-11-06 | ASND | -2.49 | 1.09 | 4.83 |
| 2026-11-09 | ASND | -2.49 | 1.57 | 4.83 |
| 2026-11-10 | ASND | -2.49 | 1.57 | 4.83 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
1.12
Avg. EPS Est. Next Quarter
1.42
Insider Transactions
-2.49
Institutional Transactions
1.57
Beta
0.38
Average Sales Estimate Current Quarter
365
Average Sales Estimate Next Quarter
410
Fair Value
198.14
Quality Score
96
Growth Score
Sentiment Score
81
Actual DrawDown %
9.1
Max Drawdown 5-Year %
Target Price
305.21
P/E
19.55
Forward P/E
25.23
PEG
P/S
13.8
P/B
10.26
P/Free Cash Flow
43.34
EPS
13.12
Average EPS Est. Cur. Y
10.08
EPS Next Y. (Est.)
8.9
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
70.99
Relative Volume
1.17
Return on Equity vs Sector %
25.3
Return on Equity vs Industry %
45.1
EPS 1 7Days Diff
-2.7
EPS 1 30Days Diff
-2.71
EBIT Estimation
579.2
◆
ASND
Healthcare
$256.59
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
62.6
Range 1M
88.9%
Sup Dist
0.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
484.6%
EPS NY
-37.3%
52W%
72.6%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-30.5% upside
Upside
-30.5%
Quality
96
MoS
-23%
ASND — P/E HistoricalBiotechnology
Ascendis Pharma A/SSector: Healthcare
Industry: Biotechnology
Employees: 1189
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
ASND
Latest News
—
Caricamento notizie per ASND…
stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today
news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025
marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance
stock history ASND – Ascendis Pharma A/S invest stock market
stock prices ASND premarket after hours
ticker ASND fair value insiders trading